This compound is primarily used in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of molecules that target central nervous system disorders, such as anxiety, depression, and neurodegenerative diseases. Its structure allows for modifications that enhance binding affinity to specific receptors, making it valuable in the design of potent and selective therapeutic agents. Additionally, it is explored in the development of compounds with potential anti-inflammatory and analgesic properties, contributing to advancements in pain management and immune-related therapies.